FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000906310> ?p ?o ?g. }

• W2000906310 endingPage "676" @default.
• W2000906310 startingPage "672" @default.
• W2000906310 abstract "PRM-151, recombinant human Pentraxin-2 (PTX-2) also referred to as serum amyloid P (SAP), is under development for treatment of fibrosis. A First-in-Human (FIH) trial was performed to assess the safety, tolerability, and pharmacokinetics of single ascending intravenous doses of PRM-151 administered to healthy subjects, using a randomized, blinded, placebo controlled study design. Each cohort included three healthy subjects (PRM-151:placebo; 2:1). SAP levels were assessed using a validated ELISA method, non-discriminating between endogenous and exogenous SAP. At a dose level of 10 mg/kg, at which a physiologic plasma level of SAP was reached, two additional healthy volunteers and three pulmonary fibrosis (PF) patients were enrolled enabling comparison of the pharmacokinetic SAP profile between healthy volunteers and PF patients. In addition, the percentage of fibrocytes (CD45+/Procollagen-1+ cells) in whole blood samples was assessed to demonstrate biological activity of PRM-151 in the target population. PRM-151 administration was generally well tolerated. In two pulmonary fibrosis patients non-specific, transient skin reactions (urticaria and erythema) were observed. PRM-151 administration resulted in a 6-to 13-fold increase in mean baseline plasma SAP levels at dose levels of 5, 10, and 20 mg/kg. The estimated t1/2 of PRM-151 in healthy volunteers was 30 h. Pharmacokinetic profiles were comparable between healthy volunteers and PF patients. PRM-151 administration resulted in a 30–50% decrease in fibrocyte numbers 24 h post-dose. This suggests that administration of PRM-151 may be associated with a reduction of fibrocytes in PF patients, a population for which current pharmacotherapeutic options are limited. The pharmacological action of PRM-151 should be confirmed in future research." @default.
• W2000906310 created "2016-06-24" @default.
• W2000906310 creator A5004696803 @default.
• W2000906310 creator A5021841624 @default.
• W2000906310 creator A5032626967 @default.
• W2000906310 creator A5038846995 @default.
• W2000906310 creator A5039808565 @default.
• W2000906310 creator A5057083278 @default.
• W2000906310 creator A5068095052 @default.
• W2000906310 creator A5071629868 @default.
• W2000906310 creator A5074359918 @default.
• W2000906310 creator A5080990092 @default.
• W2000906310 creator A5083164288 @default.
• W2000906310 creator A5088940536 @default.
• W2000906310 date "2013-12-01" @default.
• W2000906310 modified "2023-10-10" @default.
• W2000906310 title "Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis" @default.
• W2000906310 cites W1633651668 @default.
• W2000906310 cites W1967763945 @default.
• W2000906310 cites W1968353658 @default.
• W2000906310 cites W1969818245 @default.
• W2000906310 cites W1981381519 @default.
• W2000906310 cites W1993559550 @default.
• W2000906310 cites W1995461730 @default.
• W2000906310 cites W2004697839 @default.
• W2000906310 cites W2027165635 @default.
• W2000906310 cites W2039866586 @default.
• W2000906310 cites W2066672314 @default.
• W2000906310 cites W2072687919 @default.
• W2000906310 cites W2081253240 @default.
• W2000906310 cites W2087735689 @default.
• W2000906310 cites W2096777426 @default.
• W2000906310 cites W2101048388 @default.
• W2000906310 cites W2103208579 @default.
• W2000906310 cites W2117946123 @default.
• W2000906310 cites W2119341928 @default.
• W2000906310 cites W2147416874 @default.
• W2000906310 cites W2157714897 @default.
• W2000906310 cites W2167383172 @default.
• W2000906310 cites W4252082388 @default.
• W2000906310 doi "https://doi.org/10.1016/j.pupt.2013.01.008" @default.
• W2000906310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23380438" @default.
• W2000906310 hasPublicationYear "2013" @default.
• W2000906310 type Work @default.
• W2000906310 sameAs 2000906310 @default.
• W2000906310 citedByCount "84" @default.
• W2000906310 countsByYear W20009063102013 @default.
• W2000906310 countsByYear W20009063102014 @default.
• W2000906310 countsByYear W20009063102015 @default.
• W2000906310 countsByYear W20009063102016 @default.
• W2000906310 countsByYear W20009063102017 @default.
• W2000906310 countsByYear W20009063102018 @default.
• W2000906310 countsByYear W20009063102019 @default.
• W2000906310 countsByYear W20009063102020 @default.
• W2000906310 countsByYear W20009063102021 @default.
• W2000906310 countsByYear W20009063102022 @default.
• W2000906310 countsByYear W20009063102023 @default.
• W2000906310 crossrefType "journal-article" @default.
• W2000906310 hasAuthorship W2000906310A5004696803 @default.
• W2000906310 hasAuthorship W2000906310A5021841624 @default.
• W2000906310 hasAuthorship W2000906310A5032626967 @default.
• W2000906310 hasAuthorship W2000906310A5038846995 @default.
• W2000906310 hasAuthorship W2000906310A5039808565 @default.
• W2000906310 hasAuthorship W2000906310A5057083278 @default.
• W2000906310 hasAuthorship W2000906310A5068095052 @default.
• W2000906310 hasAuthorship W2000906310A5071629868 @default.
• W2000906310 hasAuthorship W2000906310A5074359918 @default.
• W2000906310 hasAuthorship W2000906310A5080990092 @default.
• W2000906310 hasAuthorship W2000906310A5083164288 @default.
• W2000906310 hasAuthorship W2000906310A5088940536 @default.
• W2000906310 hasConcept C111113717 @default.
• W2000906310 hasConcept C112705442 @default.
• W2000906310 hasConcept C126322002 @default.
• W2000906310 hasConcept C142724271 @default.
• W2000906310 hasConcept C197934379 @default.
• W2000906310 hasConcept C204787440 @default.
• W2000906310 hasConcept C27081682 @default.
• W2000906310 hasConcept C2778375690 @default.
• W2000906310 hasConcept C2780559512 @default.
• W2000906310 hasConcept C2908647359 @default.
• W2000906310 hasConcept C71924100 @default.
• W2000906310 hasConcept C90924648 @default.
• W2000906310 hasConcept C98274493 @default.
• W2000906310 hasConcept C99454951 @default.
• W2000906310 hasConceptScore W2000906310C111113717 @default.
• W2000906310 hasConceptScore W2000906310C112705442 @default.
• W2000906310 hasConceptScore W2000906310C126322002 @default.
• W2000906310 hasConceptScore W2000906310C142724271 @default.
• W2000906310 hasConceptScore W2000906310C197934379 @default.
• W2000906310 hasConceptScore W2000906310C204787440 @default.
• W2000906310 hasConceptScore W2000906310C27081682 @default.
• W2000906310 hasConceptScore W2000906310C2778375690 @default.
• W2000906310 hasConceptScore W2000906310C2780559512 @default.
• W2000906310 hasConceptScore W2000906310C2908647359 @default.
• W2000906310 hasConceptScore W2000906310C71924100 @default.
• W2000906310 hasConceptScore W2000906310C90924648 @default.
• W2000906310 hasConceptScore W2000906310C98274493 @default.
• W2000906310 hasConceptScore W2000906310C99454951 @default.

• next